Notice of Registration - 2013
[Federal Register Volume 78, Number 78 (Tuesday, April 23, 2013)]
[Notices]
[Page 23959]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09529]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
PCAS-Nanosyn, LLC
By Notice dated January 15, 2013, and published in the Federal
Register on January 30, 2013, 78 FR 6350, PCAS-Nanosyn, LLC, 3331-B
Industrial Drive, Santa Rosa, California 95403, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the following basic classes of controlled
substances:
| Drug |
Schedule |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Methylphenidate (1724) |
II |
| Phencyclidine (7471) |
II |
| Codeine (9050) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Hydrocodone (9193) |
II |
| Methadone (9250) |
II |
| Morphine (9300) |
II |
| Oxymorphone (9652) |
II |
| Fentanyl (9801) |
II |
The company is a contract manufacturer. At the request of the
company's customers, it manufactures derivatives of controlled
substances in bulk form only.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
PCAS-Nanosyn, LLC., to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated PCAS-Nanosyn, LLC., to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance
with 21 CFR Sec. 1301.33, the above named company is granted
registration as a bulk manufacturer of the basic classes of controlled
substances listed.
Dated: April 16, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-09529 Filed 4-22-13; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
